|
Mr. Costa brings to Labopharm's Board more than 30 years of experience in the pharmaceutical industry in senior counsel and senior executive roles. Mr. Costa is currently Of Counsel with Maupin Taylor P.A. of Raleigh, North Carolina specializing in corporate law for healthcare companies. Previously, Mr. Costa held the role Vice Chairman and before that President and Chief Operating Officer of Quintiles Transnational Corporation. Prior to joining Quintiles, Mr. Costa held the positions of General Counsel and Senior Vice-President Administration with Glaxo Inc., US Area Counsel with Merrell Dow Pharmaceuticals and Food & Drug Counsel with Norwich Eaton Pharmaceuticals.
In addition to Labopharm, Mr. Costa currently serves as director of a number of health sciences companies, including NPS Pharmaceuticals, Inc. (Nasdaq:NPSP), CV Therapeutics, Inc. (Nasdaq:CVTX), Digiscripts and Constella Group and is chairman of NeuroMedix Inc. (TSXV:NMX). Mr. Costa is an Adjunct Professor in teh clinical research program at the Campbell University School of Pharmacy. | 